Novel anti-bmpr1b antibodies and methods of use
US-2021261670-A1 · Aug 26, 2021 · US
This page is not indexed by search engines while we improve data quality.
Saunders Laura patents
Saunders Laura is listed as an inventor on 54 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Saunders Laura |
| Total patents | 54 |
| First publication | Nov 1, 2016 |
| Latest publication | Aug 26, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
Light chain variable regions
US-11033634-B2 · Jun 15, 2021 · US
Anti-BMPR1B antibodies and methods of use
US-10934359-B2 · Mar 2, 2021 · US
Anti sez6 antibodies and methods of use
US-2020181256-A1 · Jun 11, 2020 · US
Dll3 modulators and methods of use
US-2020138969-A1 · May 7, 2020 · US
Anti SEZ6 antibodies and methods of use
US-10533051-B2 · Jan 14, 2020 · US
Anti-MFI2 antibodies and methods of use
US-10428156-B2 · Oct 1, 2019 · US
Dll3 modulators and methods of use
US-2019247510-A1 · Aug 15, 2019 · US
Anti-dll3 antibody drug conjugates and methods of use
US-2019225685-A1 · Jul 25, 2019 · US
Anti-dll3 drug conjugates for treating tumors at risk of neuroendocrine transition
US-2019201542-A1 · Jul 4, 2019 · US
Recent patents
Latest publications not already listed above.
Anti-ascl1 antibodies and methods of use
US-2019194319-A1 · Jun 27, 2019 · US
Anti-DLL3 antibodies and drug conjugates for use in melanoma
US-10308721-B2 · Jun 4, 2019 · US
Novel anti-bmpr1b antibodies and methods of use
US-2019153103-A1 · May 23, 2019 · US
Novel anti-tnfrsf21 antibodies and methods of use
US-2019127476-A1 · May 2, 2019 · US
Novel anti-claudin antibodies and methods of use
US-2019077876-A1 · Mar 14, 2019 · US
Dll3 modulators and methods of use
US-2019046656-A1 · Feb 14, 2019 · US
Anti-DPEP3 antibodies and methods of use
US-10189910-B2 · Jan 29, 2019 · US
Novel anti-mmp16 antibodies and methods of use
US-2019022242-A1 · Jan 24, 2019 · US
Novel sez6 modulators and methods of use
US-2019022241-A1 · Jan 24, 2019 · US
Novel anti-tnfsf9 antibodies and methods of use
US-2019016812-A1 · Jan 17, 2019 · US
Anti-DLL3 antibody drug conjugates for treating cancer
US-10137204-B2 · Nov 27, 2018 · US
Anti-claudin antibodies and methods of use
US-10053511-B2 · Aug 21, 2018 · US
SEZ6 modulators and methods of use
US-9993566-B2 · Jun 12, 2018 · US
Anti-DLL3 antibody drug conjugates and methods of use
US-9937268-B2 · Apr 10, 2018 · US
Methods of delivering DLL3 antibody drug conjugates
US-9931421-B2 · Apr 3, 2018 · US
Methods of making DLL3 antibody drug conjugates
US-9931420-B2 · Apr 3, 2018 · US
Methods of making dll3 antibody drug conjugates
US-2018036421-A1 · Feb 8, 2018 · US
Methods of delivering dll3 antibody drug conjugates
US-2018036422-A1 · Feb 8, 2018 · US
Methods of delivering DLL3 antibody drug conjugates
US-9878053-B2 · Jan 30, 2018 · US
Anti-dll3 antibody drug conjugates and methods of use
US-2018015178-A1 · Jan 18, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Abbvie Stemcentrx Llc | 54 |
| Stemcentrx Inc | 3 |
| Stem Centrx Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 52 |
| C07K2317/24 | 52 |
| C07K2317/77 | 50 |
| C07K2317/33 | 48 |
| A61K2039/505 | 48 |